Hoosiers Work for Health

Hoosiers Work for Health More information is available at hoosiersworkforhealth.org.

Raising awareness among policymakers, key opinion leaders and the media of the significant social and economic value of the biopharmaceutical sector in Indiana. Hoosiers Work for Health is the Indiana chapter of a national initiative that unites health consumers, biopharmaceutical company employees, vendors, suppliers and other business and community partners to demonstrate how these diverse group

s are vital to the socioeconomic climate and provide shared benefits and a better quality of life to all. Specifically, the partnership includes local chambers of commerce and research centers, labor, businesses, patient advocacy organizations, provider groups and biopharmaceutical research companies that work together to improve America’s health care system and strengthen our economy.

Patient stories like this one are why 340B reform matters. From The Alliance for Integrity and Reform of 340B:"I trusted...
07/31/2026

Patient stories like this one are why 340B reform matters. From The Alliance for Integrity and Reform of 340B:

"I trusted that the healthcare system and programs designed to support people like me would help make treatments more affordable. That is what I believed the 340B program was doing. But I was wrong."

Cancer survivor Daria Ross shares how 340B is failing patients. Read her story in The Detroit News:

A cancer survivor explains why the 340B drug program often fails to lower costs for vulnerable patients.

The healthcare cost debate keeps missing the real driver. Hospital prices are up 281% since 2000, and hospitals now acco...
07/21/2026

The healthcare cost debate keeps missing the real driver. Hospital prices are up 281% since 2000, and hospitals now account for a third of national health spending. New report on why policy fuels it and what reform looks like.

Washington has spent years debating health care costs without confronting the biggest one. The single largest driver of America's health spending problem is hospitals. Not only does Washington largely

ICYMI: China closing in but US leads in biotech quality, commercial reach, survey finds. "The U.S. is still leading, but...
06/30/2026

ICYMI: China closing in but US leads in biotech quality, commercial reach, survey finds.

"The U.S. is still leading, but confidence ⁠is eroding. Most said they see China as an existential threat," said Seema Kumar, CEO at Cure, which is an affiliate of investment ​firm Deerfield Management.

China, which now conducts ‌more clinical drug trials than the U.S., still lags in the quality and commercial reach of its biomedical science, according to a recent survey of senior U.S. leaders in industry and academia.

June is Alzheimer's & Brain Awareness Month. Over 7 million Americans are living with Alzheimer’s, and nearly 13 million...
06/11/2026

June is Alzheimer's & Brain Awareness Month. Over 7 million Americans are living with Alzheimer’s, and nearly 13 million serve as their caregivers. Two-thirds of Americans have at least one major potential risk factor for dementia.

While there is currently no cure for Alzheimer’s, we are at a turning point in what we know about brain health.Science shows us that positive actions can make a real difference helping to reduce the risk of cognitive decline and protect brain health. It’s never too early or too late.

Take the (re)think your brain 6-Step Challenge, a step-by-step guide to help you take charge of your brain health. Sign up today at rethinkyourbrain.org. https://www.alz.org/rethink-your-brain

Discover 6 science-backed steps to support brain health and protect your memory and thinking — tips on exercise, diet, sleep & more. Get started now.

CHECK THIS OUT: Fox Business reports the federal 340B Drug Pricing Program is facing allegations of fraud and hospital p...
06/09/2026

CHECK THIS OUT: Fox Business reports the federal 340B Drug Pricing Program is facing allegations of fraud and hospital profiteering, with critics warning low-income patients are being left behind while healthcare systems reap billions.

FOX Business’ Gerri Willis reports the federal 340B Drug Pricing Pr...

Making prescription drugs more accessible and affordable sounds great in theory, but everyone seems to have different id...
06/04/2026

Making prescription drugs more accessible and affordable sounds great in theory, but everyone seems to have different ideas on how to make that happen. Adina Lasser, director of public policy and government relations for Alliance for Aging Research, breaks down the complex landscape of federal drug pricing policy with Medical Economics and what patients and physicians need to know.

A policy expert explains what physicians need to know when patients ask about the changing prices of their medicines.

"If a charity organization collected billions of dollars with little evidence that needy people benefited, regulators an...
05/28/2026

"If a charity organization collected billions of dollars with little evidence that needy people benefited, regulators and the public would quickly demand answers.
Yet many large hospital systems participating in the federal 340B Drug Pricing Program are quietly doing just that—extracting billions in drug discounts with scarce oversight and no obligation to prove vulnerable patients benefit."

-Sally Pipes, President, CEO, Thomas W. Smith Fellow in Health Care Policy at the Pacific Research Institute

When hospitals overcharge insurers for drugs they bought at deep 340B discounts, taxpayers, employers, and insured patients foot the bill.

European experts are not speaking hypothetically. As director of the Austrian Economics Center and a member of Austria’s...
05/26/2026

European experts are not speaking hypothetically. As director of the Austrian Economics Center and a member of Austria’s National Council, Barbara Kolm has direct experience with the European drug pricing systems some want the U.S. to adopt. Her warning about the risks to innovation and future cures should not be taken lightly.

Today, medical leaps that once took decades are now happening in months.

For families managing serious or chronic conditions, copay assistance can mean the difference between getting treatment ...
05/18/2026

For families managing serious or chronic conditions, copay assistance can mean the difference between getting treatment or going without it.

Indiana’s new patient-first laws help ensure those savings actually reach patients instead of being absorbed by insurance companies and pharmacy benefit managers. National Kidney Foundation of Indiana CEO Liz Ellis explains why these reforms matter for Hoosier families.

Indiana lawmakers have taken bold steps to put patients ahead of harmful insurance practices. Hoosier patients, not insurance giants, should start benefiting at the pharmacy counter.

Address

Indianapolis, IN

Website

Alerts

Be the first to know and let us send you an email when Hoosiers Work for Health posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Hoosiers Work for Health:

Shortcuts

Share

Category